Dr Stephen Schleicher Previews Nashville IVBM Meeting

Stephen M. Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, previews the Nashville meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), co-hosted by Tennessee Oncology.

Stephen M. Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, previews the Nashville meeting of The American Journal of Managed Care®'s (AJMC®) Institute for Value-Based Medicine® (IVBM), co-hosted by Tennessee Oncology. At the event in Nashville, Tennessee, on April 21, 2022, experts will discuss advancing value-based cancer care.


Who are you excited to see at the Nashville meeting of IVBM? What can attendees expect to learn from these speakers?

I'm very excited for this AJMC® IVBM conference in Nashville next Thursday, co-hosted by Tennessee Oncology. We have a great lineup of speakers and panelists, some focused on technology.

Bobby Green [MD] will be our first speaker. An oncologist, he was chief medical officer of Flatiron Health, now president at Thyme Care—a cancer navigation program that's just had a great fundraising seed from Andreessen Horowitz for their focus on helping patients navigate the entire cancer journey. Data and analytics is a big piece of that, to identify those patients that really need extra support from additional nurses, social workers, etc., to help with symptom management, keeping patients out of the hospital, a lot of the things that the Oncology Care Model taught us about as well, so that's going to be great.

We have Elaine Goodman, [MD, MBA] one of my close friends and colleagues from Brigham [and Women's Hospital] and Harvard Business School, who's one of the smartest people I know. She's done some great work with a company, Wellframe, which also helps with patient engagement. [She] now helps lead population health for the entire Mass General Brigham Women's Health System, as well as has spent time running the urgent care at Mass General Hospital. She's going to be phenomenal.

We have Ravi Parikh, [MD, MPP, FACP] also, who trained with me and Elaine at the Brigham, who does a lot of great work with provider engagement, helping early palliative care interventions. He's actually doing some work with Tennessee Oncology, which we're excited about, which we'll talk about. And then we have Hillary Cavanagh from [Center for Medicare & Medicaid Innovation], who's going to be able to speak to us about her takeaways from the Oncology Care Model. We're really excited that Hillary can join us.

And then a really exciting and unique panel of 3 of the top health care investment venture capitalists that I'm aware of. Ben Robbins [MD, MBA] from Google Ventures, who sat on the board of Aspire Health, a large cognitive care company that was bought by Anthem. We have Brenton Fargnoli, [MD, MBA] who also trained with me at Brigham in residency, who is at AlleyCorp [Healthcare Fund], who was a lead investor in Thyme Care. And Chris Booker, a good friend in Nashville at Frist Cressey, who has been involved with tons of health care innovation companies. Monogram [Health] is also a Frist Cressey investor to OneOncology.

So, a lot of exciting people to discuss what we've learned and where we're headed in the future. Technology is a piece of that but, in general, where's health care going to be in the next 5 years? How are we going to push towards innovation? I'm excited to hear what they can all offer. And Leah [Owens, DNP, RN, BMTCN, OCN], my co-host, and myself can't wait for the event.

Why are in-person meetings important for physicians as the country emerges from the pandemic?

In-person meetings are incredibly valuable to help us both learn in person from the speakers and panelists, but also at this conference, I can't wait for us all to learn from each other who are attending. It's going to be a great networking event. We have representative leaders from Tennessee Oncology, OneOncology, Ascension, Vanderbilt; we have even some Blue Cross there—our large commercial payer partner who has helped us build a medical home.

It's going to be great. We have over 100 people attending in-person and I can't wait for us to all be together and learn from our speakers and from each other at this event.

Related Videos
Samyukta Mullangi, MD, MBA
David Maahs, MD, PhD
Sheila Garland, PhD, MSc, Memorial University
Andrew McHill, PhD, Oregon Health and Science University
Dayna Johnson, PhD, MPH, MSW, MS, Rollins School of Public Health at Emory University
Travis Brewer, vice president of payer relations, Texas Oncology
Ariel Williamson, PhD, DBSM, Children's Hospital of Philadelphia/Perelman School of Medicine
Judite Blanc, PhD, Miller School of Medicine/University of Miami
Related Content
© 2023 MJH Life Sciences
All rights reserved.